Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
161M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
-7.89M
-
Total reported value, excl. options
-
$24.1M
-
Value change
-
-$19.9M
-
Put/Call ratio
-
0.12
-
Number of buys
-
35
-
Number of sells
-
-57
-
Price
-
$0.62
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q2 2024
120 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
of 161M outstanding shares and own 24.3% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (5.11M shares), VANGUARD GROUP INC (4.64M shares), MORGAN STANLEY (4.45M shares), Versant Venture Management, LLC (3.56M shares), Alyeska Investment Group, L.P. (3.46M shares), DEUTSCHE BANK AG\ (3.23M shares), Artal Group S.A. (3.03M shares), FMR LLC (1.61M shares), GOLDMAN SACHS GROUP INC (1.16M shares), and MILLENNIUM MANAGEMENT LLC (1.11M shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.